Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: Susceptibility to cytolysis reflects Schwann cell phenotype
- 31 January 1994
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 49 (1-2) , 145-152
- https://doi.org/10.1016/0165-5728(94)90190-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- In vitro demyelination by serum antibody from patients with guillain‐barré syndrome requires terminal complement complexesAnnals of Neurology, 1991
- Characterization of complement‐fixing antibodies to peripheral nerve myelin in Guillain‐Barré syndromeAnnals of Neurology, 1990
- Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complementNature, 1989
- Complement receptors CR1 on human peripheral nerve fibresJournal of Neuroimmunology, 1988
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Neuropathological findings in Miller Fisher syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- In vivo demyelinating activity of sera from patients with Guillain‐Barré syndromeAnnals of Neurology, 1982
- Immunological characterization of surd nerve biopsies from patients with Guillain-Barr syndromeAnnals of Neurology, 1981
- Pathology of the Guillain-Barr syndromeAnnals of Neurology, 1981
- Transfer of demyelination by intraneul injection of experimental allergic neuritis serumNature, 1978